Key takeaways

  • Define the requested material before comparing suppliers or prices.
  • Keep product specifications, lot-specific reports and purchasing terms as separate records.
  • Read every analytical result with its method, units and stated acceptance criterion.
  • A missing attribute remains unknown; another product or lot cannot fill the gap.
  • Preserve the ordered variant, received lot and document versions in one traceable file.

Start with a written material requirement

Write the requested material before opening supplier pages. Include the exact name or project identifier, sequence or structural reference when available, relevant modifications, chemical form, required presentation, amount per vial and number of vials. For a blend, define each component and its required amount or ratio. This becomes the comparison baseline rather than a description reconstructed from whichever listing appears first.

FDA’s Q6A guidance defines a specification as a set of tests, analytical procedures and acceptance criteria. Research catalog materials are not automatically governed by that guidance, but the structure is a useful model: a quality claim is reviewable only when the attribute, method and criterion are connected. Record where a supplier provides less than the laboratory requires.

Confirm identity and nomenclature

Check whether the product name uniquely identifies the material. Capture sequence, terminal modifications, conjugates, isotopic labels, stereochemical details, salt or counterion information and other qualifiers where they are relevant. Preserve aliases as search aids, but choose one controlled name for the purchasing record and link each alias to its source.

Do not treat similar spelling, capitalization or a shared base name as evidence of equivalence. Modified and unmodified peptides, different salt forms and different components within a branded blend require separate review. If the listing relies on a shorthand term that can describe more than one material, request a fuller identifier.

Define composition, form and quantity

Record whether the item is a single material or a blend, the stated physical form, all declared components and the basis of the labeled amount. Keep nominal amount per vial and pack quantity in separate fields. For a formulated material, determine whether the labeled mass refers to the named peptide, the complete dry contents or another stated basis.

Do not assume that “lyophilized,” “10 mg” or “research grade” supplies the missing composition. These terms answer different or incomplete questions. If excipients, counterions, residuals or blend ratios matter to the project and are not declared, place them on the open-questions list.

Match the evidence to the offered lot

A product specification describes what the material is intended to meet. A certificate or analytical report records results for an identified sample. Compare the lot or batch identifier on the report with the lot offered or received, and record the issuing laboratory, report date and revision. A literature citation, representative certificate or report for a different lot does not close that traceability step.

Preserve the complete report instead of copying only a headline percentage. If the storefront cannot identify which lot will ship, record that limitation and establish how the matching documentation will be obtained. When a report is revised, keep its relationship to the earlier version clear.

Read methods, results and criteria together

For every result, identify the measured attribute, analytical procedure, units, result and stated acceptance criterion. ICH Q2(R2) frames validation around whether an analytical procedure is suitable for its intended purpose, while Q14 addresses development of procedures for the attributes being evaluated. The name of an instrument alone does not show that a method is suitable for a particular claim.

Identity, chromatographic purity, assay or content, water and residual solvents are distinct attributes. A chromatographic area percentage is not automatically a mass balance, and a molecular-mass result is not automatically a quantitative content result. Note which questions each reported method addresses and which required attributes remain unreported.

Review the supplier and transaction fields

Capture the legal or trading name of the supplier, catalog number, support route and published terms. Record the selected variant, unit price, number of units, currency, merchandise total and the delivery and returns terms presented for the destination. A low displayed price cannot compensate for an undefined material or a report that cannot be tied to the supplied lot.

Save the order confirmation and any written answers that clarify the specification. Marketing claims belong in a separate notes field unless they are connected to a defined attribute and evidence. This prevents broad phrases such as “high purity” or “premium quality” from being mistaken for a complete specification.

Reconcile the received material

Compare the received product name, container count, amount per vial, catalog reference and lot identifier with the order record. Then connect the lot to its report. List discrepancies exactly as found rather than correcting them in the local record. Ask the supplier for a documented resolution and retain that response with the purchase file.

A batch record should show what was requested, what the supplier stated, what was ordered and what arrived. Keeping those stages distinct makes it possible to review a change in specification, a substituted lot or a corrected certificate without overwriting the original evidence.

Use a clear status for every required field

Mark each checklist item as confirmed, not provided, not applicable or pending clarification. Add the source and review date for every confirmed value. “Not provided” is a meaningful outcome because it prevents an empty field from being read later as an affirmative result. “Not applicable” should include the reason it does not apply to that material.

The checklist supports purchasing judgment; it does not certify a supplier or batch. Laboratory requirements determine which fields are mandatory. Regulatory quality guidances offer useful vocabulary and structure, but referencing them does not establish regulatory approval, compliance or suitability for a particular research program.

Practical checklist

  1. Exact product name and unambiguous material identity
  2. Sequence, modification, salt or counterion information where applicable
  3. Single material or blend, with each blend component and amount defined
  4. Physical form and any declared formulation components
  5. Quantity basis, nominal amount per vial and number of vials
  6. Catalog number or SKU and supplier identity
  7. Lot or batch identifier on both material and report
  8. Analytical methods, results, units and stated acceptance criteria
  9. Report issuer, report date and document revision
  10. Currency, item total, delivery terms and retained order confirmation

Sources and further reading

These sources describe the cited methods, reference compounds or published studies. They do not verify the identity, purity or performance of any Peptine Labs lot.

  1. FDA: Q6A Specifications and Acceptance Criteria
  2. FDA: Q2(R2) Validation of Analytical Procedures
  3. FDA: Q14 Analytical Procedure Development
  4. FDA: Analytical Procedures and Methods Validation for Drugs and Biologics
  5. NIST: The International System of Units (SI), 2019 Edition
← Back to the Research Peptide Blog